tradingkey.logo
搜索

Amneal Pharmaceuticals Inc

AMRX
添加自选
17.310USD
+0.020+0.12%
收盘 06/30, 16:00美东报价延迟15分钟
5.52B总市值
44.64市盈率 TTM

关于 Amneal Pharmaceuticals Inc 公司

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Inc简介

公司代码AMRX
公司名称Amneal Pharmaceuticals Inc
上市日期Nov 18, 2009
CEOPatel (Chintu)
员工数量8100
证券类型Ordinary Share
年结日Nov 18
公司地址400 Crossing Boulevard, 3rd Floor
城市BRIDGEWATER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编08807
电话19089473120
网址https://amneal.com/
公司代码AMRX
上市日期Nov 18, 2009
CEOPatel (Chintu)

Amneal Pharmaceuticals Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

常见问题

Amneal Pharmaceuticals Inc的前五大股东是谁?

Amneal Pharmaceuticals Inc 的前五大股东如下:Mr. Chintu Patel

有多少机构持有Amneal Pharmaceuticals Inc(AMRX)的股份?

截至2026Q1,共有521家机构持有Amneal Pharmaceuticals Inc的股份,合计持有的股份价值约为161.64M,占公司总股份的50.67%。与2025Q4相比,机构持股有所增加,增幅为-25718515.00。

哪个业务部门对Amneal Pharmaceuticals Inc的收入贡献最大?

在2026Q1,Oral solid业务部门对Amneal Pharmaceuticals Inc的收入贡献最大,创收726.38M,占总收入的24.06%。
KeyAI